Beijing Tong Ren Tang Chinese Medicine Company Limited (FRA:TQR)

Market Cap	815.76M
Revenue (ttm)	200.41M
Net Income (ttm)	62.21M
Shares Out	n/a
EPS (ttm)	0.07
PE Ratio	13.11
Forward PE	n/a
Dividend	0.04 (4.06%)
Ex-Dividend Date	May 30, 2025

Volume	2,000
Average Volume	800
Open	0.9700
Previous Close	0.9750
Day's Range	0.9700 - 0.9700
52-Week Range	0.8100 - 1.2300
Beta	n/a
RSI	47.52
Earnings Date	Apr 29, 2025

About FRA:TQR

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. The company operates through three segments: Hong Kong, Mainland China, and Overseas. It also offers Chinese medical consultation and treatment services. The company operates retail outlets in Hong Kong and in other countries and regions in Asia, Oceania, North America, and Europe. It markets its products under the Tong Ren Tang brand...

• Industry: Drug Stores and Proprietary Stores
• Founded: 1669
• Employees: 782
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TQR

Financial Performance

In 2024, FRA:TQR's revenue was 1.61 billion, an increase of 5.69% compared to the previous year's 1.52 billion. Earnings were 500.28 million, a decrease of -7.42%.

Financial numbers in HKD